# A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer

> clinical trial · VERIFIED · 2026-07-06

Status: ACTIVE_NOT_RECRUITING · Sponsor: Janssen Research & Development, LLC · Condition: Prostatic Neoplasms

- Company: Janssen Research & Development, LLC
- Sector: Prostatic Neoplasms
- Primary source: https://clinicaltrials.gov/study/NCT03523442

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.